LoginRegister
    Alembic Pharma gets USFDA nod for Solifenacin Succinate tablets to treat overactive bladderAlembic Pharma gets USFDA nod for Solifenacin Succinate tablets to treat overactive bladder
    Merck to buy cancer drug developer Peloton Therapeutics for $1.05 billion in cashMerck to buy cancer drug developer Peloton Therapeutics for $1.05 billion in cash
    Drug Alert: CDSCO declares 31 samples as sub-standard in quality in random sampling; DetailsDrug Alert: CDSCO declares 31 samples as sub-standard in quality in random sampling; Details
    Glenmark Pharma gets USFDA nod for generic version of Vesicare tabletsGlenmark Pharma gets USFDA nod for generic version of Vesicare tablets
    CCI dismisses complaint against Cipla, chemist body over alleged non-supply of medicinesCCI dismisses complaint against Cipla, chemist body over alleged non-supply of medicines
    GSK Pharma Q4 net profit rises 16.56 percent to Rs 123 croreGSK Pharma Q4 net profit rises 16.56 percent to Rs 123 crore
    Supreme Court sends back Merck Fosamax lawsuit to lower courtSupreme Court sends back Merck Fosamax lawsuit to lower court
    Investors keep food firms on warning over antibioticsInvestors keep food firms on warning over antibiotics
    Red Flag: CDSCO warns against Medtronic pacemaker for battery related malfunctionRed Flag: CDSCO warns against Medtronic pacemaker for battery related malfunction
    JnJ largest India plant for cosmetics, baby products stand idle three years after completionJnJ largest India plant for cosmetics, baby products stand idle three years after completion
    Patent Infringement: AstraZeneca moves court against Aurobindo Pharma on generic version of DalirespPatent Infringement: AstraZeneca moves court against Aurobindo Pharma on generic version of Daliresp
    Delhi High Court stays Centres circular banning manufacture, sale of e-cigarettesDelhi High Court stays Centres circular banning manufacture, sale of e-cigarettes
    Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

    Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

    © 2025 - Medical Dialogues. All Rights Reserved.
    Powered By: Hocalwire
    X